tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
BEAM is currently covered by 10 analysts with an average price target of $52.67. This is a potential upside of $25.12 (91.18%) from yesterday's end of day stock price of $27.55.
Beam Therapeutics 's activity chart (see below) currently has 111 price targets and 81 ratings on display. The stock rating distribution of BEAM is 70.59% BUY and 29.41% HOLD.
Analysts average stock forecasts to be materialized ratio is 32.86% with an average time for these price targets to be met of 66.87 days.
Highest price target for BEAM is $70, Lowest price target is $20, average price target is $40.13.
Most recent stock forecast was given by MICHAEL YEE from UBS on 09-Oct-2025. First documented stock forecast 02-Mar-2020.
Currently out of the existing stock ratings of BEAM, 12 are a BUY (70.59%), 5 are a HOLD (29.41%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 09-Oct-2025
$41
$13.86 (51.07%)
$30
3 months ago
(09-Oct-2025)
3/4 (75%)
$13.13 (47.11%)
177
Hold
Since 10-Aug-2022
$21
$-6.14 (-22.62%)
$25
5 months 3 days ago
(06-Aug-2025)
11/11 (100%)
$2.7 (14.75%)
145
Buy
Since 05-Jan-2022
$55
$27.86 (102.65%)
$78
8 months 2 days ago
(07-May-2025)
0/4 (0%)
$38.77 (238.88%)
Buy
Since 16-Feb-2021
$70
$42.86 (157.92%)
$105
8 months 2 days ago
(07-May-2025)
0/3 (0%)
$53.77 (331.30%)
Since 20-Dec-2022
$40
$12.86 (47.38%)
$57
8 months 17 days ago
(23-Apr-2025)
2/5 (40%)
$20.13 (101.31%)
4
What is BEAM (Beam Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?
Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?
Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?
